Administration of the combination Clonazepam-Deanxit as treatment for tinnitus

Otology and Neurotology

Volumn 32, Issue 4, 2011, Pages 701-709

  Meeus, Olivier ^a   De Ridder, Dirk ^a   Van De Heyning, Paul ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Clonazepam; Deanxit; Flupentixol; Melitracen; Tinnitus

Indexed keywords

ANTHRACENE DERIVATIVE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CLONAZEPAM; FLUPENTIXOL; FLUPENTIXOL, MELITRACEN DRUG COMBINATION;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TINNITUS; TREATMENT OUTCOME;

ADULT; ANTHRACENES; CLONAZEPAM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; FLUPENTHIXOL; GABA MODULATORS; HUMANS; MALE; PROSPECTIVE STUDIES; TINNITUS; TREATMENT OUTCOME;

EID: 79957998101     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e31820e737c     Document Type: Article

References (38)

1. Heller AJ. Classification and epidemiology of tinnitus. Otolaryngol Clin North Am 2003;36:239-48. (Pubitemid 36529941)
2. Langguth B, Salvi R, Elgoyhen AB. Emerging pharmacotherapy of tinnitus. Expert Opin Emerg Drugs 2009;14:687-702.
3. Elgoyhen AB, Langguth B. Pharmacological approaches to the treatment of tinnitus. Drug Discov Today 2009.
4. Baldo P, Doree C, Lazzarini R, et al. Antidepressants for patients with tinnitus. Cochrane Database Syst Rev 2006;CD003853.
5. Patterson MB, Balough BJ. Review of pharmacological therapy for tinnitus. Int Tinnitus J 2006;12:149-59. (Pubitemid 46032585)
6. Gananca MM, Caovilla HH, Gananca FF, et al. Clonazepam in the pharmacological treatment of vertigo and tinnitus. Int Tinnitus J 2002;8:50-3. (Pubitemid 34701028)
7. Cagnotto A, Parotti L, Mennini T. In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study. Eur J Pharmacol 1996;313:63-7. (Pubitemid 26342206)
8. de Azevedo AA, Langguth B, de Oliveira PM, et al. Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions. Otol Neurotol 2009;30:676-80.
9. Lopez-Gonzalez MA, Santiago AM, Esteban-Ortega F. Sulpiride and melatonin decrease tinnitus perception modulating the auditolimbic dopaminergic pathway. J Otolaryngol 2007;36:213-9. (Pubitemid 47518412)
10. Goebel G, Hiller W. [The tinnitus questionnaire. A standard instrument for grading the degree of tinnitus. Results of a multicenter study with the tinnitus questionnaire] Tinnitus-Fragebogen. HNO 1994;42:166-72. (Pubitemid 24119762)
11. Hallam RS, Jakes SC, Hinchcliffe R. Cognitive variables in tinnitus annoyance. Br J Clin Psychol 1988;27(Pt 3):213-22.
12. Meeus O, Blaivie C, Van de Heyning P. Validation of the Dutch and the French version of the Tinnitus Questionnaire. B-ENT 2007;3:11-7. (Pubitemid 350156603)
13. Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 1984;40:1365-7. (Pubitemid 15177028)
14. Khalfa S, Dubal S, Veuillet E, et al. Psychometric normalization of a hyperacusis questionnaire. ORL J Otorhinolaryngol Relat Spec 2002;64:436-42. (Pubitemid 36091902)
15. Meeus OM, Spaepen M, De Ridder D, et al. Correlation between hyperacusis measurements in daily ENT practice. Int J Audiol 2010; 49:7-13.
16. Moller AR. Tinnitus: Presence and future. Prog Brain Res 2007; 166:3-16. (Pubitemid 47588055)
17. Moller AR. The role of neural plasticity in tinnitus. Prog Brain Res 2007;166:37-45.
18. Robinson S. Antidepressants for treatment of tinnitus. Prog Brain Res 2007;166:263-71. (Pubitemid 47593013)
19. Salvi R, Lobarinas E, Sun W. Pharmacological treatments for tinnitus: Old and new. Drugs Future 2009;34:381-400.
20. Sullivan M, Katon W, Russo J, et al. A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch Intern Med 1993;153: 2251-9. (Pubitemid 23296492)
21. Robinson SK, Viirre ES, Bailey KA, et al. Randomized placebocontrolled trial of a selective serotonin reuptake inhibitor in the treatment of nondepressed tinnitus subjects. Psychosom Med 2005; 67:981-8. (Pubitemid 43740113)
22. Zoger S, Svedlund J, Holgers KM. The effects of sertraline on severe tinnitus sufferingYa randomized, double-blind, placebocontrolled study. J Clin Psychopharmacol 2006;26:32-9. (Pubitemid 43167088)
23. Lopez-Gonzalez MA, Moliner-Peiro F, Faro-Garcia J, et al. Sulpiride plus hydroxyzine decrease tinnitus perception. Auris Nasus Larynx 2007;34:23-7. (Pubitemid 46136870)
24. Hyttel J. Flupentixol and dopamine receptor selectivity. Psychopharmacology (Berl) 1981;75:217. (Pubitemid 12228836)
25. Lopez-Gonzalez MA, Esteban-Ortega F. Tinnitus dopaminergic pathway. Ear noises treatment by dopamine modulation. Med Hypotheses 2005;65:349-52. (Pubitemid 40744766)
26. Llinas R, Urbano FJ, Leznik E, et al. Rhythmic and dysrhythmic thalamocortical dynamics: GABA systems and the edge effect. Trends Neurosci 2005;28:325-33. (Pubitemid 40775778)
27. Shulman A, Strashun AM, Goldstein BA. GABAA-benzodiazepinechloride receptor-targeted therapy for tinnitus control: Preliminary report. Int Tinnitus J 2002;8:30-6. (Pubitemid 34701025)
28. Bahmad FM Jr, Venosa AR, Oliveira CA. Benzodiazepines and GABAergics in treating severe disabling tinnitus of predominantly cochlear origin. Int Tinnitus J 2006;12:140-4. (Pubitemid 46032583)
29. Bakhshaee M, Ghasemi M, Azarpazhooh M, et al. Gabapentin effectiveness on the sensation of subjective idiopathic tinnitus: A pilot study. Eur Arch Otorhinolaryngol 2007;265:525-30. (Pubitemid 351661077)
30. Witsell DL, Hannley MT, Stinnet S, et al. Treatment of tinnitus with gabapentin: A pilot study. Otol Neurotol 2007;28:11-5. (Pubitemid 46052235)
31. Brozoski TJ, Spires TJ, Bauer CA. Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model. J Assoc Res Otolaryngol 2007;8:105-18. (Pubitemid 46214123)
32. Morishita S. Clonazepam as a therapeutic adjunct to improve the management of depression: A brief review. Hum Psychopharmacol 2009;24:191-8.
33. Morishita S, Aoki S, Watanabe S. Clonazepam as a therapeutic adjunct to improve the management of psychiatric disorders. Psychiatry Clin Neurosci 1998;52:75-8. (Pubitemid 28188983)
34. Morishita S, Arita S. Possible predictors of response to clonazepam augmentation therapy in patients with protracted depression. Hum Psychopharmacol 2007;22:27-31. (Pubitemid 46178775)
35. Keller HH, Schaffner R, Haefely W. Interaction of benzodiazepines with neuroleptics at central dopamine neurons. Naunyn Schmiedebergs Arch Pharmacol 1976;294:1-7.
36. Tenn CC, Niles LP. Mechanisms underlying the antidopaminergic effect of clonazepam and melatonin in striatum. Neuropharmacology 1997;36:1659-63. (Pubitemid 28085926)
37. Thaker GK, Nguyen JA, Strauss ME, Jacobson R, Kaup BA, Tamminga CA. Clonazepam treatment of tardive dyskinesia: A practical GABAmimetic strategy. Am J Psychiatry 1990;147:445-51. (Pubitemid 20107108)
38. Fritze J, Spreda I. Tolerability of low dose neuroleptics: A case control study of flupenthixol. Eur Neuropsychopharmacol 1997;7:261-6.